Coronary Stent Market - Trends Forecast Till 2028

Coronary Stent Market is segmented by Product Type (Drug-eluting Stent, Bare Metal Coronary Stent, and Bioabsorbable Stent), Biomaterial, End User, and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-HC-CSM-800

Format:  

Number of Pages: 315

Domain: Healthcare

Coronary Stent Market – Trends Forecast Till 2028

The global Coronary Stent Market size is projected to reach a CAGR of 8.9% during the forecast period 2021-2028.

Coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

The increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents are some of the factors that have supported long-term expansion for Coronary Stent Market.

The current outbreak of COVID - 19 has affected the coronary stents market in several ways. The business complexities arising from the current pandemic has created confusion with respect to the production of medical devices.

Coronary Stent Market Research Report

North America holds the largest market share for coronary stents due to the dominance of the top companies present in the global market. There is also an increase in the aging population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.

Coronary Stent Market is segmented into Product type, biomaterial, end user and region.

On the basis of Product Type

  • Drug eluting stent
  • Bare metal coronary stent
  • Bioabsorbable stent

On the basis of Biomaterial  

  • Metallic biomaterial
  • Polymeric biomaterial
  • Natural biomaterial

On the basis of End-User  

  • Hospitals
  • Ambulatory surgical centres  

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Coronary Stent Market Primary Respondent

 

Key Players

  • Abbott Laboratories
  • B. Braun Medical Inc.
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation

Recent Developments

  • In May 2018, Abbott announced that it has received approval for Xience Sierra. The product is the newest generation of the company’s gold standard Xience everolimus-eluting coronary stent system. Abbott’s latest approval will not just benefit the company but will have a direct impact on the growth of the overall market in the coming years.
  • Abbott received U.S. FDA approval for Xience Sierra in May 2018, which is a XIENCE everolimus-eluting coronary stent system.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Coronary Stent Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Growth Rate

CAGR of 8.9% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product type, biomaterial, end user and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Abbott Laboratories, B. Braun Medical Inc., Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG and Boston Scientific Corporation.

Available Customization

In addition to the market data for Coronary Stent Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.